List of insiders holdings for TransMedics Group Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures 2007 General Partner LLC Flagship Ventures Fund 2007 L.P. AFEYAN NOUBAR 10% Owner |
2019-10-31 19:00:29 | 0 2,960,786 |
2,960,786 | Form 4 |
| 2 | ABRAMS CAPITAL MANAGEMENT L.P. ABRAMS CAPITAL MANAGEMENT LLC Abrams Capital Partners II L.P. ABRAMS CAPITAL LLC Abrams David C Riva Capital Partners III L.P. Riva Capital Management III LLC 10% Owner |
2021-02-16 16:01:08 | 1,302,612 0 |
1,302,612 | Form 13G |
| 3 | Hassanein Waleed H President & CEO |
2025-02-26 18:16:52 | 211,609 469,359 |
680,968 | Form 4 |
| 4 | KANIA EDWIN M JR Director |
2024-05-28 17:30:16 | 259,830 46,142 |
305,972 | Form 4 |
| 5 | Godhani Rakesh P. Chief Digital Officer |
2021-08-06 17:05:31 | 140,000 0 |
140,000 | Form 4 |
| 6 | Corcoran Nicholas See Remarks |
2025-02-26 18:12:20 | 52,860 0 |
52,860 | Form 4 |
| 7 | Provost Miriam VP, Global Regulatory Affairs |
2023-12-15 17:31:17 | 46,045 0 |
46,045 | Form 4 |
| 8 | Gordon Stephen Chief Financial Officer |
2024-06-05 17:12:25 | 36,716 0 |
36,716 | Form 4 |
| 9 | Khayal Tamer I Chief Commercial Officer |
2025-03-05 16:30:17 | 36,042 0 |
36,042 | Form 4 |
| 10 | Carey John F VP of Operations |
2023-02-03 17:12:57 | 32,550 0 |
32,550 | Form 4 |
| 11 | Sullivan John F VP of Quality & Engineering |
2021-09-01 17:04:44 | 30,045 0 |
30,045 | Form 4 |
| 12 | Ranganath Anil P. See remarks |
2025-02-26 18:09:57 | 23,120 0 |
23,120 | Form 4 |
| 13 | Hernandez Gerardo Chief Financial Officer |
2025-02-26 18:15:00 | 21,283 0 |
21,283 | Form 4 |
| 14 | TOBIN JAMES R Director |
2024-09-17 19:27:27 | 1,925 18,000 |
19,925 | Form 4 |
| 15 | DAMME LAURA VP, Clinical Affairs |
2023-02-22 20:00:40 | 14,390 0 |
14,390 | Form 4 |
| 16 | Weill David Director |
2024-05-31 16:30:07 | 10,732 0 |
10,732 | Form 4 |
| 17 | Lovell Stephanie Director |
2024-05-28 17:30:11 | 3,079 0 |
3,079 | Form 4 |
| 18 | RAINES MERILEE Director |
2024-05-28 17:30:17 | 3,079 0 |
3,079 | Form 4 |
| 19 | Gunderson Thomas James Director |
2024-05-28 17:30:41 | 3,079 0 |
3,079 | Form 4 |
| 20 | Basile Edward M Director |
2024-11-07 16:30:11 | 732 0 |
732 | Form 4 |
| 21 | UNITED THERAPEUTICS Corp Lung Biotechnology PBC 10% Owner |
2021-02-05 06:04:18 | 0 0 |
0 | Form 13G |
| 22 | Gilbert James Director |
2019-05-01 19:06:22 | 0 0 |
0 | Form 3 |